Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a narrative opinion review summarizing MRI literature on anxiety in late life over 15 years, identifying neurobiological patterns and research gaps rather than presenting new empirical evidence or a definitive synthesis.
Small, single-centre computational modelling study with surrogate behavioural endpoints in a narrow population; identifies mechanistic patterns but lacks the scale, replication, or clinical outcome data needed for stronger evidence grades.
An expert consensus meeting report that defines research priorities and recommendations for anhedonia assessment and treatment, rather than reporting primary empirical findings.
This is a conceptual framework paper proposing a multidimensional model of insight in depression, without empirical validation, control groups, or outcome data to support its claims.
A well-designed cross-sectional study demonstrating graded dose–response relationships between EEG biomarkers and depression severity across a continuous spectrum, but limited by lack of prospective validation, treatment outcome data, or clinical utility thresholds.
International Journal of Pharmaceutical Quality Assurance
Single-centre retrospective observational study describing clinical characteristics and treatment patterns in GAD; no control group, no intervention testing, and no hard clinical outcomes reported.
International Journal of Pharmaceutical Quality Assurance
Retrospective descriptive study of clinical features in a single tertiary centre with no comparator, control group, or intervention—documents prevalence and associations but does not test efficacy or causation.